IMPROVAC FOR PIGS

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

GNRF - PROTEIN CONJUGATE; CHLOROCRESOL

Available from:

ZOETIS AUSTRALIA PTY LTD

INN (International Name):

GnRF-protein conjugate(150ug/mL)

Pharmaceutical form:

MISC. VACCINES OR ANTI SERA

Composition:

GNRF - PROTEIN CONJUGATE BIOLOGICAL-PROTEIN Active 150.0 ug/ml; CHLOROCRESOL PHENOL Other 1.0 mg/ml

Units in package:

100mL; 20mL; 250mL

Class:

VM - Veterinary Medicine

Manufactured by:

ZOETIS AUSTRALIA

Therapeutic area:

IMMUNOTHERAPY

Product summary:

Poison schedule: 4; Withholding period: WITHHOLDING PERIODS: Zero (0) days EX PORT SLAUGHTER INTERVAL (ESI): Zero (0) days.; Host/pest details: PIG SOW (FEMALE): [OESTRUS SUPPRESSION, REDUCE ASSOCIATED SEXUAL BEHAVIOUR (STANDING OESTRUS), REDUCE INCIDENCE OF UNWANTED PREGNANCIES IN GILTS ]; PIGS: [BOAR TAINT]; Poison schedule: 4; Withholding period: WITHHOLDING PERIODS: Zero (0) days EX PORT SLAUGHTER INTERVAL (ESI): Zero (0) days.; Host/pest details: PIGS: [BOAR TAINT]; Poison schedule: 4; Withholding period: WITHHOLDING PERIODS: Zero (0) days; Host/pest details: PIGS: [BOAR TAINT]; For the production of heavier entire male pigs with improved meat quality through the control of boar taint; for behavioural modification which may be evidenced by increased weight gain in peripubertal male pigs during the post-vaccination preslaughter...This product is contraindicated for use in male pig breeding stock. Inadvertent vaccination of male pig breeding stock may affect subsequent fertility.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

Product Name:
APVMA Approval No:
IMPROVAC FOR PIGS
70058/134374
Label Name:
IMPROVAC FOR PIGS
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS
Constituent
Statements:
Each 2 mL dose of vaccine contains ≥ 300 μg GnRF-protein conjugate.
Chlorocresol 1.0 mg/mL has been added as a preservative.
Claims:
For use by or under direction of a registered veterinarian.
Male pigs:
For the production of heavier entire male pigs with improved meat
quality through the
control of boar taint; for behavioural modification which may be
evidenced by increased
weight gain in peripubertal male pigs during the post-vaccination
preslaughter period. This
increased weight gain may also result in increased fat deposition.
Female pigs:
Induction of antibodies against GnRF to produce a temporary
immunological suppression
of ovarian function (suppression of oestrus) in order to reduce the
incidence of unwanted
pregnancies in gilts intended for slaughter, and to reduce the
associated sexual behaviour
(standing oestrus).
Net Contents:
20 mL (10 doses)
100 mL (50 doses)
250 mL (125 doses)
Directions for Use:
Restraints:
Contraindications:
This product is contraindicated for use in male and female pig
breeding stock. RLP APPROVED
Inadvertent vaccination of male and female pig breeding stock may
affect subsequent
fertility.
Precautions:
Side Effects:
Some swelling may develop at the site of vaccination, which in a small
proportion of pigs,
may last for several weeks before gradually subsiding.
Dosage and
Administration:
Use the contents within 28 days of first broaching the vial. Discard
the unused portion.
On each subsequent reuse, swab the opening with a suitable
disinfectant (for example,
methylated sprits) both before and after using. See RESEALING section
for more
information.
The dose on all occasions is 2 mL injected subcutaneously (just under
the skin). The
recommended site for injection is at the base of the neck, immediately
behind the ear using
a safety vaccinat

Summary of Product characteristics

Issue date: 10-July-2017
Version number: 01
SAFETY DATA SHEET
1. IDENTIFICATION
IMPROVAC FOR MALE PIGS (APVMA NO. 70058)
PRODUCT IDENTIFIER
None.
OTHER MEANS OF IDENTIFICATION
RECOMMENDED USE OF THE CHEMICAL AND RESTRICTIONS ON USE
Veterinary vaccine
RECOMMENDED USE
Not for human use
RESTRICTIONS ON USE
DETAILS OF MANUFACTURER OR IMPORTER
COMPANY NAME (AU)
Zoetis Australia Pty Ltd
ABN 94 156 476 425
Level 6, 5 Rider Boulevard
Rhodes NSW 2138 AUSTRALIA
TEL
1800 814 883
FAX
[phone]
EMAIL
[e-mail]
EMERGENCY PHONE
1800 814 883 (all hours)
POLICE AND FIRE BRIGADE
Dial 000
IF INEFFECTIVE
Dial Poisons Information Centre (13 1126 from anywhere in Australia)
2. HAZARD(S) IDENTIFICATION
CLASSIFICATION OF THE HAZARDOUS CHEMICAL
Not classified.
PHYSICAL HAZARDS
Category 1B
Reproductive toxicity
HEALTH HAZARDS
Not classified.
ENVIRONMENTAL HAZARDS
LABEL ELEMENTS, INCLUDING PRECAUTIONARY STATEMENTS
HAZARD SYMBOL(S)
Health
hazard
SIGNAL WORD
Danger
HAZARD STATEMENT(S)
May damage fertility or the unborn child.
PRECAUTIONARY STATEMENT(S)
PREVENTION
Obtain special instructions before use. Do not handle until all safety
precautions have been read
and understood. Use personal protective equipment as required.
RESPONSE
IF exposed or concerned: Get medical advice/attention.
STORAGE
Store locked up.
DISPOSAL
Dispose of contents/container in accordance with
local/regional/national/international regulations.
OTHER HAZARDS WHICH DO NOT
RESULT IN CLASSIFICATION
None known.
SUPPLEMENTAL INFORMATION
Contains 4-CHLORO-M-CRESOL. May produce an allergic reaction. In the
event of systemic
exposure, this material may cause immune system reactions in humans.
Systemic exposure may
affect reproductive hormone regulation and thus affect fertility and
maintenance of pregnancy.
Pregnant women should not administer this product. Women and men of
childbearing age should
exercise extreme caution when handling this product. In the event of
accidental injection, an
allergic reaction may occur. Accidental self injection could